Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Nat Cancer. 2022 Dec 29;4(1):27–42. doi: 10.1038/s43018-022-00480-0

Extended Data Fig. 2 |. Separation of malignant and microenvironment cells in AML samples.

Extended Data Fig. 2 |

a. InferCNV heatmaps for patients with clinically annotated chromosome gains or losses. b. InferCNV heatmaps for healthy donor BM samples. c. UMAP projection of Healthy donors, CNV+ and CNV− cells from patients with annotated chromosome gains or losses (left), quantification of malignant and microenvironment cells for each sample (right).